Bioavailability Normalization
Bioavailability Normalization is a methodological framework in pharmacokinetics that standardizes drug exposure measures across individuals or formulations by adjusting for differences in the rate and extent of active drug reaching the systemic circulation.
5
Publications
191
Citations
26
Authors
14
Institutions
Publications per year
2017–2026
2
Parents
5
Optimization of trans-Resveratrol bioavailability for human therapy
Marie Josèphe Amiot, Béatrice Romier, Thi-Mai Anh Dao et al. · Biochimie · 2013 · 91 citations
Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats
Jinping Zhou, Rui Zhang, Pengpeng Guo et al. · Frontiers in Microbiology · 2022 · 18 citations · Full text
Christian E. Schlekat, William A. Stubblefield, Kathryn Gallagher · Environmental Toxicology and Chemistry · 2019 · 14 citations · Full text
1–5 of 5
26
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 26
14
Université de Montréal
Montreal, Canada
1 h-index
1 publications
91 citations
Union Hospital
Shatin, China
1 h-index
11 publications
198 citations
Environmental Protection Agency
Accra, Ghana
1 h-index
1 publications
14 citations
Environmental Protection Agency
Washington, United States
1 h-index
1 publications
14 citations
Inserm
Paris, France
1 h-index
4 publications
364 citations
Environmental Protection Agency
Wexford, Ireland
1 h-index
1 publications
14 citations
Aix-Marseille Université
Marseille, France
1 h-index
5 publications
455 citations

Huazhong University of Science and Technology
Wuhan, China
1 h-index
11 publications
198 citations
1–8 of 14
Repository · 1 publications · 16 citations
1
h-index
DIA · 1 publications · 52 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 18 citations
1
h-index
1 publications · 91 citations
1
h-index
1–5